The novel therapy of the medication represents a major development in the care of the condition. Distinct from existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide688176.ambien-blog.com/48909358/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment